Meta-analysis of oxaliplatin-based versus fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer. - Wikidata - wikimedia - TriplyDB

Meta-analysis of oxaliplatin-based versus fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer.

Meta-analysis of oxaliplatin-based versus fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer.

http://www.wikidata.org/entity/Q33798353

about

Additional 4-week capecitabine during the resting periods after 6-week neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: long-term oncologic outcomes.

P2860

Q54936297-9B215F94-AB12-4EA7-8F6E-B6FD3325EDF6

P2860

Meta-analysis of oxaliplatin-based versus fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer.

http://www.wikidata.org/entity/Q33798353

description

2017 nî lūn-bûn

@nan

2017 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մարտին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Meta-analysis of oxaliplatin-b ...... ocally advanced rectal cancer.

@ast

Meta-analysis of oxaliplatin-b ...... ocally advanced rectal cancer.

@en

type

label

Meta-analysis of oxaliplatin-b ...... ocally advanced rectal cancer.

@ast

Meta-analysis of oxaliplatin-b ...... ocally advanced rectal cancer.

@en

prefLabel

Meta-analysis of oxaliplatin-b ...... ocally advanced rectal cancer.

@ast

Meta-analysis of oxaliplatin-b ...... ocally advanced rectal cancer.

@en

P1433

Q33798353-ECF25712-3494-49E7-93EF-CD90B710B95D

P1476

Q33798353-4259BC8A-E3F7-457D-ABF2-37A090A63685

P2093

Q33798353-27C62862-C3B7-4C7D-8EED-BE8490614085

Q33798353-48217133-B952-4E8A-851A-C3F763D3B0B8

Q33798353-BFC045D3-45F4-4E7A-A38F-5AEE17A7FEB5

Q33798353-C04B351F-FFDF-4136-A027-D6D732ECD9FE

Q33798353-E6F87D27-4EE9-43B7-9E21-C9E81646CAF0

Q33798353-F1B08F5D-14E4-48D0-8DE9-DD0DA6466E3E

Q33798353-F55044D1-1528-42EB-8A89-BEA7D25DD069

Q33798353-FAA65196-435B-4757-8061-129743AD5A4E

P2860

Q33798353-0147F361-3F55-42BE-8BEC-7B6A3D55D70C

Q33798353-026C109E-752E-4061-A660-F8693C53B31B

Q33798353-049D4A6D-8CEC-47B7-82EB-8FFF4537B7E8

Q33798353-0854812B-2F76-4DC0-8703-38AC311DF5B7

Q33798353-0A96D80C-C338-40C6-B868-C38E1ADEDEE0

Q33798353-0E26D768-06C1-45C4-A36C-73B50E28FECB

Q33798353-196BEEAE-06C1-491C-9864-B733F88A0C64

Q33798353-2C203AC6-3ACD-4F59-8628-079084509A62

Q33798353-34634060-AD75-46E3-9DA8-0B9A48A265D9

Q33798353-392677DC-FBA8-4DD5-B0CA-71FBCFE7BC9C

P304

Q33798353-C7C74986-FC68-49E6-AB7E-278A30F0A736

P31

Q33798353-BCBFAB57-0B84-4EB9-ADE5-61DE3CC18101

Q33798353-e35b9ef7-9d2a-48bc-8777-24105d0da877

P356

Q33798353-BB543F78-E49D-4765-9182-CCC16F866033

P407

Q33798353-3885E6EC-D7A8-4A20-BBF5-85CCF3CC8414

P433

Q33798353-1217656C-D372-4DF1-86B3-C523B15BCC88

P478

Q33798353-E1A3AA13-7375-46A0-9CBB-D8FAD42A6EBF

P577

Q33798353-4482F717-1235-49A3-A423-752FD4A37F17

P698

Q33798353-535AC9F5-D195-429A-97F2-730E6F84FE1D

P921

Q33798353-0587F8AA-52D0-40F6-B7A9-C7234D95060D

P932

Q33798353-38407047-AE8D-44C0-B4CA-DA918A701422

P356

ONCOTARGET.16127

P1433

P1476

Meta-analysis of oxaliplatin-b ...... ocally advanced rectal cancer.

@en

P2093

Guo-Qing Tao

http://www.w3.org/2001/XMLSchema#string

Jian-Qiang Wang

http://www.w3.org/2001/XMLSchema#string

Liang-Hui Shu

http://www.w3.org/2001/XMLSchema#string

Xing-Li Fu

http://www.w3.org/2001/XMLSchema#string

Yong-Jie Zhang

http://www.w3.org/2001/XMLSchema#string

Zheng Fang

http://www.w3.org/2001/XMLSchema#string

Zhi-Lian Rui

http://www.w3.org/2001/XMLSchema#string

Zhi-Qiang Tian

http://www.w3.org/2001/XMLSchema#string

P2860

Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer

Neoadjuvant Rectal (NAR) Score: a New Surrogate Endpoint in Rectal Cancer Clinical Trials

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012

Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data.

Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.

Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04

Chemotherapy with preoperative radiotherapy in rectal cancer.

Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial.

P304

34340-34351

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.16127

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28423720

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

5470972

http://www.w3.org/2001/XMLSchema#string